P-2-purinoceptor antagonists .2. Blockade of P-2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue

被引:38
|
作者
Wittenburg, H
Bultmann, R
Pause, B
Ganter, C
Kurz, G
Starke, K
机构
[1] UNIV FREIBURG,INST PHARMAKOL,D-79104 FREIBURG,GERMANY
[2] UNIV FREIBURG,INST ORGAN CHEM & BIOCHEM,D-79104 FREIBURG,GERMANY
关键词
rat vas deferens; guinea-pig taenia coli; P-2-purinoceptor antagonists; P-2X-purinoceptor; P-2Y-purinoceptor; ecto-nucleotidase; Evans blue; trypan blue;
D O I
10.1007/BF00168441
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effects of Evans blue and four derivatives as well as of trypan blue and four derivatives, mostly smaller fragments but two compounds with an additional ethylene bridge in the center of the molecule, were studied on contractions of the rat vas deferens elicited by alpha,beta-methylene ATP (alpha,beta-MeATP; mediated by P-2X-purinoceptors), relaxations of the carbachol-precontracted guinea-pig taenia coli elicited by adenosine 5'-O-(2-thiodiphosphate) (ADP beta S; mediated by P-2Y-purinoceptors), and the degradation of ATP by rat vas deferens tissue. All compounds shifted the concentration-response curve of alpha,beta-MeATP in the rat vas deferens to the right, and most compounds increased the maximum of the curve. Each member of the Evans blue series was similar in potency to the corresponding member of the trypan blue series. Where three concentrations were tested, the Arunlakshana-Schild regression was linear, and the slope did not differ from 1. The apparent K-d values were between 0.8 and 385 mu M. In the guinea-pig taenia coli, only the members of the trypan blue group were relatively potent, shifting the concentration-response curve of ADP beta S to the right in a surmountable manner. In 2 of 3 cases where three concentrations were tested, the slope of the Arunlakshana-Schild regression was lower than 1. Apparent K-d values in the trypan blue group were between 5.2 and 324 mu M. The removal of ATP from the medium by vas deferens tissue was decreased mainly by the members of the Evans blue group, with IC25% values between 13 and 158 (in 1 case > 1000) mu M. The results indicate that the position of the sulphonate residues at the terminal naphthalene rings of these compounds hardly influences P-2X purinoceptor affinity but greatly influences P-2Y affinity and ecto-nucleotidase blockade. Among active compounds, apparent purinoceptor affinity and ecto-nucleotidase blockade increase with the size of the molecules up to Evans blue and trypan blue themselves; introduction of a central ethylene bridge does not result in a further gain in potency. NH01, the desmethyl derivative of Evans blue, seems to be interesting because it is the compound with the highest P-2X- versus P-2Y-selectivity presently available.
引用
收藏
页码:491 / 497
页数:7
相关论文
共 50 条
  • [1] P-2-purinoceptor antagonists .3. Blockade of P-2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin
    Bultmann, R
    Wittenburg, H
    Pause, B
    Kurz, G
    Nickel, P
    Starke, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 354 (04) : 498 - 504
  • [2] P-2-purinoceptor antagonists .1. Blockade of P-2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates
    Bultmann, R
    Pause, B
    Wittenburg, H
    Kurz, G
    Starke, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 354 (04) : 481 - 490
  • [3] Design and pharmacology of selective P-2-purinoceptor antagonists
    Lambrecht, G
    JOURNAL OF AUTONOMIC PHARMACOLOGY, 1996, 16 (06): : 341 - 344
  • [4] P2-receptor antagonists:: IV.: Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2
    Tuluc, F
    Bültmann, R
    Glänzel, M
    Frahm, AW
    Starke, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (02) : 111 - 120
  • [5] P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2
    Florin Tuluc
    R. Bültmann
    Markus Glänzel
    August Wilhelm Frahm
    Klaus Starke
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 357 : 111 - 120
  • [6] DIFFERENTIAL EXPRESSION OF P-2-PURINOCEPTOR SUBTYPES IN ADRENOMEDULLARY CELLS
    CASTRO, E
    TOME, AJR
    MATEO, J
    BARBOSA, RM
    ROSARIO, LM
    MIRASPORTUGAL, MT
    FASEB JOURNAL, 1995, 9 (03): : A117 - A117
  • [7] ANTINOCICEPTIVE EFFECT OF INTRATHECALLY ADMINISTERED P-2-PURINOCEPTOR ANTAGONISTS IN RATS
    DRIESSEN, B
    REIMANN, W
    SELVE, N
    FRIDERICHS, E
    BULTMANN, R
    BRAIN RESEARCH, 1994, 666 (02) : 182 - 188
  • [8] EFFECT OF P-2-PURINOCEPTOR ANTAGONISTS ON GLUTAMATERGIC TRANSMISSION IN THE RAT HIPPOCAMPUS
    MOTIN, L
    BENNETT, MR
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) : 1276 - 1280
  • [9] INDICATIONS FOR P-2-PURINOCEPTOR SUBTYPES IN GUINEA-PIG SMOOTH-MUSCLE
    WIKLUND, NP
    GUSTAFSSON, LE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (03) : 361 - 370
  • [10] IONIC DEPENDENCE OF A P-2-PURINOCEPTOR MEDIATED DEPOLARIZATION OF CULTURED ASTROCYTES
    MAGOSKI, NS
    WALZ, W
    JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 32 (04) : 530 - 538